Anlon Healthcare

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0Y8W01017
  • NSEID: AHCL
  • BSEID: 544497
INR
133.75
-4 (-2.9%)
BSENSE

Jan 19

BSE+NSE Vol: 63.59 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10039733,
    "name": "Anlon Healthcare",
    "stock_name": "Anlon Healthcare",
    "full_name": "Anlon Healthcare Ltd",
    "name_url": "stocks-analysis/anlon-healthcare",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "133.75",
    "chg": -4,
    "chgp": "-2.9%",
    "dir": -1,
    "prev_price": "137.75",
    "mcapval": "712.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 544497,
    "symbol": "AHCL",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0Y8W01017",
    "curr_date": "Jan 19",
    "curr_time": "",
    "bse_nse_vol": "63.59 k",
    "exc_status": "Active",
    "traded_date": "Jan 19, 2026",
    "traded_date_str": "2026 01 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/anlon-healthcare-10039733-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "10039733",
    "stock_news_url": "https://www.marketsmojo.com/news/anlon-healthcare-10039733"
  },
  "announcements": [
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "09-Jan-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Neomile Growth Fund Series I",
      "source": "BSE"
    },
    {
      "caption": "Announcement With Continuation Of Our Earlier Intimation Dated December 02 2025 Regarding The Execution Of Share Purchase Agreement Dated December 2 2025.",
      "datetime": "09-Jan-2026",
      "details": "We have attached herewith announcement as per Reg. 30 of SEBI (LODR) Regulation 2015. Kindly take the same on your record. Thank you.",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "09-Jan-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Neomile Growth Fund Series I",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

09-Jan-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Neomile Growth Fund Series I

Announcement With Continuation Of Our Earlier Intimation Dated December 02 2025 Regarding The Execution Of Share Purchase Agreement Dated December 2 2025.

09-Jan-2026 | Source : BSE

We have attached herewith announcement as per Reg. 30 of SEBI (LODR) Regulation 2015. Kindly take the same on your record. Thank you.

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

09-Jan-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Neomile Growth Fund Series I

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available